Product Performance Platform

What we are studying

The purpose of this study is to collect information over time regarding how Medtronic systems are working in patients. The entire system includes the device (IPG, ICD, or CRT), the lead(s), and all associated parts. Medtronic has been collecting information about how their products work for over 25 years. This study is also being used to collect information needed by the Food and Drug Administration (FDA) in the United States to see how devices are working.

Who we are studying

Men and Women
Races:
- White
- African American
- Asian
- American Indian or Alaska Native
- Native Hawaiian or Pacific Islander
- Other
All Ethnicities
Ages 18+

Eligibility Criteria

Must be implanted or is intended to be implanted with at least one Medtronic market-released product
Must enroll within 30 days of implant or must have participated in the pre-market study phase for the product

What is involved

Participants may be in the study for as long as they have Medtronic products
Those with defibrillators or heart failure devices (ICD or CRT) will be seen every 6 months
Those with a pacemaker (IPG) will be seen every 12 months